DE69911374D1 - Triazolopiridazinederivate als gaba rezeptor-liganden - Google Patents

Triazolopiridazinederivate als gaba rezeptor-liganden

Info

Publication number
DE69911374D1
DE69911374D1 DE69911374T DE69911374T DE69911374D1 DE 69911374 D1 DE69911374 D1 DE 69911374D1 DE 69911374 T DE69911374 T DE 69911374T DE 69911374 T DE69911374 T DE 69911374T DE 69911374 D1 DE69911374 D1 DE 69911374D1
Authority
DE
Germany
Prior art keywords
derivatives
triazolopiridazine
receptor ligands
gaba receptor
alpha2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69911374T
Other languages
English (en)
Inventor
Andrew Madin
Pate Owens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Application granted granted Critical
Publication of DE69911374D1 publication Critical patent/DE69911374D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69911374T 1998-01-21 1999-01-13 Triazolopiridazinederivate als gaba rezeptor-liganden Expired - Lifetime DE69911374D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9801208.1A GB9801208D0 (en) 1998-01-21 1998-01-21 Therapeutic agents
PCT/GB1999/000105 WO1999037645A1 (en) 1998-01-21 1999-01-13 Triazolo-pyridazine derivatives as ligands for gaba receptors

Publications (1)

Publication Number Publication Date
DE69911374D1 true DE69911374D1 (de) 2003-10-23

Family

ID=10825601

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69911374T Expired - Lifetime DE69911374D1 (de) 1998-01-21 1999-01-13 Triazolopiridazinederivate als gaba rezeptor-liganden

Country Status (9)

Country Link
US (1) US6355798B1 (de)
EP (1) EP1049697B1 (de)
JP (1) JP2002501067A (de)
AT (1) ATE250062T1 (de)
AU (1) AU748001B2 (de)
CA (1) CA2315213A1 (de)
DE (1) DE69911374D1 (de)
GB (1) GB9801208D0 (de)
WO (1) WO1999037645A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9929687D0 (en) * 1999-12-15 2000-02-09 Merck Sharp & Dohme Therapeutic agents
AR031473A1 (es) * 2000-11-20 2003-09-24 Lundbeck & Co As H Intensificadores de gaba en el tratamiento de enfermedades relacionadas con una reducida actividad neuroesteroide
WO2002083139A1 (en) * 2001-04-10 2002-10-24 Merck & Co., Inc. Inhibitors of akt activity
US6960584B2 (en) 2001-04-10 2005-11-01 Merck & Co., Inc. Inhibitors of Akt activity
JP2004527531A (ja) * 2001-04-10 2004-09-09 メルク　エンド　カムパニー　インコーポレーテッド 癌を治療する方法
US6958334B2 (en) 2001-04-10 2005-10-25 Merck & Co., Inc. Inhibitors of Akt activity
DE602005021894D1 (de) * 2004-09-02 2010-07-29 Nycomed Gmbh Triazolophthalazine
EP2275095A3 (de) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenese durch modulation des Muscarinrezeptors
EP2258359A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin
US7985756B2 (en) 2005-10-21 2011-07-26 Braincells Inc. Modulation of neurogenesis by PDE inhibition
EP1942879A1 (de) 2005-10-31 2008-07-16 Braincells, Inc. Gaba-rezeptor-vermittelte modulation von neurogenese
BRPI0620292B1 (pt) * 2005-12-21 2021-08-24 Janssen Pharmaceutica N. V. Compostos de triazolopiridazinas como moduladores da cinase, composição, uso, combinação e processo de preparo do referido composto
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド アンジオテンシン調節による神経新生
JP2010502722A (ja) 2006-09-08 2010-01-28 ブレインセルス，インコーポレイティド ４−アシルアミノピリジン誘導体を含む組み合わせ
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
AU2010338038B2 (en) 2009-12-31 2015-07-09 Fundación Del Sector Público Estatal Centro Nacional De Investigaciones Oncológicas Carlos III (F.S.P. CNIO) Tricyclic compounds for use as kinase inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230705A (en) 1976-09-22 1980-10-28 American Cyanamid Company 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazines and their uses in treating anxiety
CA1080712A (en) 1976-09-22 1980-07-01 Jay D. Albright Hypotensive agents
US4112095A (en) 1976-10-07 1978-09-05 American Cyanamid Company 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazine hypotensive agents
PH12424A (en) 1976-10-26 1979-02-15 American Cyanamid Co Method of treating anxiety in mammals
US4260755A (en) 1979-10-31 1981-04-07 American Cyanamid Company Novel 6-phenyl and substituted 6-phenyl-1,2,4-triazolo[4,3-b]pyridazines
US4260756A (en) * 1979-11-15 1981-04-07 American Cyanamid Company 6- And 8-heteroaryl-1,2,4-triazolo[4,3-b]pyridazines
PH21834A (en) 1982-01-18 1988-03-17 Lepetit Spa New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives
IT1194310B (it) 1983-07-12 1988-09-14 Lepetit Spa Derivati triazolo (3,4-a) ftalazinici 3,6-disostituiti
US4578464A (en) * 1983-11-22 1986-03-25 Merrell Dow Pharmaceuticals Inc. 6-Hydroxyalkylamino-8-methyl-1,2,4-triazolo-[4,3-b]pyridazine and related compounds
US4654343A (en) 1985-10-31 1987-03-31 American Cyanamid Company N-substituted-N[3-(1,2,4-triazolo[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas
CZ18199A3 (cs) * 1996-07-25 1999-06-16 Merck Sharp And Dohme Limited Triazolopyridazinové deriváty, způsob výroby a farmaceutický prostředek

Also Published As

Publication number Publication date
EP1049697A1 (de) 2000-11-08
AU748001B2 (en) 2002-05-30
US6355798B1 (en) 2002-03-12
AU2065899A (en) 1999-08-09
JP2002501067A (ja) 2002-01-15
GB9801208D0 (en) 1998-03-18
EP1049697B1 (de) 2003-09-17
ATE250062T1 (de) 2003-10-15
CA2315213A1 (en) 1999-07-29
WO1999037645A1 (en) 1999-07-29

Similar Documents

Publication Publication Date Title
ATE250062T1 (de) Triazolopiridazinederivate als gaba rezeptor- liganden
TR199900047T2 (xx) Gaba resept�rleri ligandlar� olarak ikame triazolo-piridazin t�revleri
ATE270672T1 (de) Imidazopyridinderivate als liganden für gaba- rezeptoren
ATE284403T1 (de) Triazolopyridazinderivate als liganden für gaba- rezeptoren
GB0117277D0 (en) Therapeutic agents
DE60214532D1 (de) Imidazopyrimidin-derivate als liganden für gaba-rezeptoren
ATE253066T1 (de) Imidazotriazinderivate als gaba rezeptor-liganden
PL331853A1 (en) Derivatives of adenosine n6- substituted with heterocyclic groups
ATE255109T1 (de) Imidazopyridinderivate als gaba rezeptor liganden
AU1253002A (en) Imidazo-triazine derivatives as ligands for gaba receptors
BG108166A (en) Imidazo-pyrimidine derivatives as liigands for gaba receptors
GB0212048D0 (en) Therapeutic agents
DE60307462D1 (de) 8-fluorimidazo(1,2-a)pyridin derivative als liganden für gaba rezeptoren
AU2192797A (en) Synthetic derivatives of rapamycin as multimerising agents for chimeric proteins with immunophilin derived domains
ATE371659T1 (de) Pyrazolotriazinderivate als gaba-rezeptorliganden
YU1302A (sh) Derivati aminotiazola i njihova primena kao liganada crf receptora
ATE420867T1 (de) Phenylpyridazin derivative als liganden für gaba- rezeptoren
PE44299A1 (es) Derivados sustituidos de triazolo-piridacina como ligandos para receptores gaba
BG103484A (en) PREPARATION OF [1S-[1a, 2b, 3b, 4a(S*)]-4-[7-[ [1-(3-CHLOR-2-THIENYL)METHYL]PROPYL]AMINO]-3H-IMIDAZO[4,5-b]PYRIDI N-3-YL]-N-ETHYL-2,3-DIHYDROXYCYCLOPENTANE CARBOXAMIDE
TR200002100T2 (tr) GABA reseptörleri için ligandlar olarak triazolo-piridazin türevleri
NO20002407L (no) Pyrrolo[3,2-b]pyridin-fremgangsmÕter og mellomprodukter
ATE376993T1 (de) Herstellung von 3,5,7ö-1h-imidazo 1,5-aöimidazol-2(3h)-on-verb ndungen
ATE252103T1 (de) 6-substituierte 1,2,4a,5a,8a,8b-hexahydro- und 1, 2,3,4,4a,5a,8a,8b-oktahydro-6h-pyrrolo(3',4':4, 5)furo(3,2-b)pyrid-8(7h)-on derivate und ihre verwendung zur bekämpfung von endoparasiten

Legal Events

Date Code Title Description
8332 No legal effect for de